BWM
PACB icon

Brickley Wealth Management’s Pacific Biosciences PACB Stock Holding History

Brickley Wealth Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-22,000
Closed -$78K – 42
2018
Q2 		$78K Hold
22,000
– – 0.04% 25
2018
Q1 		$45K Hold
22,000
– – 0.02% 25
2017
Q4 		$58K Buy
+22,000
New +$77K 0.03% 23

Other funds holding PACB

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Brickley Wealth Management's PACB Position: Q3 2018 in Review

Brickley Wealth Management sold out of Pacific Biosciences (PACB) in Q3 2018, closing a stake of 22,000 shares — an estimated $78K sold.

Brickley Wealth Management first reported a position in PACB in Q4 2017 and held it in 3 quarters. The position peaked at $78K in Q2 2018. 118 funds tracked by Wall St. Rank hold PACB as of Q3 2018.

  • Brickley Wealth Management reported no remaining Pacific Biosciences position as of Q3 2018 after selling out during the quarter.
  • Brickley Wealth Management sold 22,000 Pacific Biosciences shares in Q3 2018, an estimated $78K.
  • Brickley Wealth Management first reported a position in Pacific Biosciences in Q4 2017 and held it in 3 quarters.
  • Brickley Wealth Management's Pacific Biosciences position peaked at $78K in Q2 2018.
  • 118 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2018.

Based on Brickley Wealth Management's 13F filing for Q3 2018, filed 13 Nov 2018.